Cargando...
Interleukin-6: a new therapeutic target in systemic sclerosis?
Interleukin-6 (IL-6) is a classic pro-inflammatory cytokine critical in mounting an effective immune response. It is secreted by a wide array of cell types; however, its effector cells are more restricted, owing to the fact that very few cells, except lymphocytes and hepatocytes, express the functio...
Guardado en:
| Publicado en: | Clin Transl Immunology |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Nature Publishing Group
2013
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4232056/ https://ncbi.nlm.nih.gov/pubmed/25505952 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cti.2013.2 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|